Механизмы развития и оценка степени тяжести при воспалительных заболеваниях легких (стр. 27 )

84.  Скулачев в живой клетке: добро и зло // Соросовский образовательный журналN3. - С. 4-10.

85.  , , Локшина ферменты и их биологические функции // Вестник Рос. акад. мед. наукN2. - С. 3-9.

86.  , , Дорохин тяжести эндотоксикоза и эффективности детоксикационной терапии // Клин. лаб. диагностика. 1994. - N7. - С. 7-9.

87.  , , Федорчук антипротеолитической системы крови при остром бронхите //8 Национальный конгресс по болезням органов дыхания. - М., 1998. - N XLI.10. - C. 344.

88.  , Хышиктуев перекисного окисления липидов как фактора риска ХНЗЛ в Забайкалье //4 Национальный конгресс по болезням органов дыхания.- М., 1994. - N 52.

89.  , Гончарова функции легких // Болезни органов дыхания ( Руководство для врачей) в 4-х томах / Под ред. - М.: Медицина,1989. - Т.1. - С. 193-201.

90.  Титов нормы в клинической биохимии // Клин. лаб. диагностикаN1. - С. 1-6.

91.  Ткачук эндокринной системы // Успехи физиологической наукиТ.25, N2. - С. 47-54.

92.  Тупикова уремические токсины (обзор литературы) // Вопр. мед. химииN1. - С. 2-10.

93.  Тупикова активность различных фракций средних молекул и их элиминация при гемосорбции у обожженных //Эфферентная терапияТ. 3, N1. - С. 53-56.

94.  , , Балашова распротсраненности острых бронхитов и острых пневмоний у взрослых и некоторые факторы их генеза // Проблемы пульмонологии. - Л.: ВНИИП, 1985. - Вып. 9. - С. 26-29.

95.  , Воль-Эпштейн легких (диагностика и лечение)./ Под ред. . М., 1976. - С. 24-29.

96.  , , Смоляр способность альбумина в оценке эндотоксемии // Вест. интенсивной терапииN4. - С. 21-23.

97.  Харьков токсины в хирургии: современные исследования в биологии и медицине. Сообщение II. Диагностика // Клин. хирургияN 11-12. - С. 90-93.

98.  Хышиктуев нарушений метаболизма липидов в патогенезе и диагностике заболеваний системы органов дыхания: Автореф. дисс. ... д-ра мед. наук. - Иркутск, 19с.

99.  Хышиктуева компонентов системы "Мать - внезародышевые органы - плод": их роль при физиологической беременности у женщин с хроническими неспецифическими заболеваниями легких: Автореф. дисс. ... д-ра мед. наук. - Иркутск, 19с.

100., , и др. Новые стратегические подходы к лечению септического шока // Международ. мед. обзорыТ. 2, N5. - С. 351-355.

101., Иванеев подходы к оценке тяжести состояния и модели предсказания прогноза у больных в педиатрическом отделении интенсивной терапии // Международ. мед. обзорыТ. 2, N5. - С. 312-318.

102.Чаленко острых нарушений функций органов и систем при синдроме полиорганной недостаточности // Анестезиология и реаниматологияN2. - С. 25-30.

103.Чучалин : актуальная проблема современной медицины // Materia MedicaN4(8). - С. 5-10.

104., , Гюльмамедов и (синдром системного воспалительного ответа) //Анестезиология и реаниматологияN4. - С. 60-64.

105., Амисеев состояния при острой пневмонии // Клин. медицинаN1. - С. 30-33.

106., , Харитонов механизмы лечебного действия и обоснование кратности проведения сеансов ультрафиолетового облучения крови в лечении острой пневмонии. Сообщение 1 // Тер. архивТ.66, N8. - С. 39-42.

107.Яковлев эндотоксемия, физиология и патология человека: Автореф. дисс. ... д-ра мед. наук. - М., 19с.

108.Яковлева липидов крови при болезнях органов дыхания // 8 Национальный конгресс по болезням органов дыхания. - М., 1998. - N XLVII.34. - C. 385.

109.Alexander B. The role of nitric oxide in hepatic metabolism //NutritionVol.14, N4. - P.376-390.

110.Alscher K. T., Phang P. T., McDonald T. E., Walley K. R. Enteral feeding decreases gut apoptosis, permeability, and lung inflammation during murine endotoxemia //Am. J. Physiol. Gastrointest. Liver Physiol.- 2001. – Vol.281, N 2. – P.569-576.

111.Amiral J. Research and development strategies in hemostasis and thrombosis // Haematologica. 1995 - Vol.80, N2. - P.14-24.

112.Arcaroli J., Yang K. Y., Yum H. K. et al. Effects of catecholamines on kinase activation in lung neutrophils after hemorrhage or endotoxemia //J. Leukoc. Biol. – 2002.- Vol.72, N3.- P.571-579.

113.Arnd, P. G., Fantuzz, G., Abraham E. Expression of interleukin-18 in the lung after endotoxemia or hemorrhage-induced acute lung injury //Am. J. Respir. Cell Mol. Biol. – 2000. - Vol22, N6. – P.708-713.

114.Berg T., Gjoen T., Bakke O. Physiological functions of endosomal proteolysis // Biochem. JVol.307, N2. - P.313-326.

115.Birrer P., McElvaney N. G., Rudeberg A. et al. Protease-antiprotease imbalance in the lungs of children with cystic fibrosis / //Am. J. Respir. Crit. Care. MedVol.150, N1. - P.207-213.

116.Bojic I. The significance of endotoxins in clinical medicine //Vojnosanit. PreglVol.50, N6. - P.596-602.

117.Booke M., Lingnau W., Hinder F. et al. Endotoxin versus bacteremia: a comparison focusing on clinical relevance // Prog. Clin. Biol. ResVol.392. - P.393-403.

118.Borodin E. A., Lopukhin Yu. M. Physicochemical basis for phospholipid therapie in the management of cholesterosis // Physicochemical Medicine Reviews. / Yu. M.Lopukhin. - London: Gordon and Breach Science Publishers, Inc., 1987. - P.205-253.

119.Brun-Buisson C., Roupie E. Septic shock. Etiology, physiopathology, diagnosis, treatment // Rev. PratVol.45, N14. - P..

120.Burcham P. C. Genotoxic lipid peroxidation products: their DNA damaging properties and role in formation of endogenous DNA adducts //MutagenesisVol.13, N3. - P.287-305.

121.Burgmann H., Breyer S. Biochemistry, molecular mechanism of action and biological effects of endotoxin // Wien. Med. WochenschrVol.145, N9. - P.211-217.

122.Caradonna L., Mastronardi M. L., Magrone T. et al. Biological and clinical significance of endotoxemia in the course of hepatitis C virus infection // Curr. Pharm. Des. – 2002.- Vol.8, N11.-.P..

123.Cardoso W. V., Sekhon H. S., Hyde D. M., et al Collagen and elastin in human pulmonary emphysema // Amer. Rev. Res pir. DisVol.147, N4. - P.975-981.

124.Cheeseman K. H. Mechanisms and effects of lipid peroxidation //Mol. Aspects. MedVol.14, N3. - P.191-197.

125.Chitano P., Hosselet J. J., Mapp C. E. et al. Effect of oxidant air pollutants on the respiratory system: insights from experimental animal research // Eur. Respir. JVol.8, N8. - P..

126.Comporti M. Lipid peroxidation. Biopathological significance //Mol. Aspects. MedVol.14, N3. - P.199-207.

127.Conroy D. M., Francischi J. N., Sirois P. Effect of tumor necrosis factor receptor binding protein on cell infiltration induced by lipopolysaccharide and Sephadex beads in guinea pig lung // Inflammation. 1995. Vol.19, N2. - P.233-243.

128.Corriveau C. C., Danner R. L. Antiendotoxin therapies for septic shock // Infect. Agents. DisVol.2, N1, - P.44-52.

129.Corriveau C. C., Danner R. L. Endotoxin as a therapeutic target in septic shock // Infect. Agents. DisVol.2, N1. - P.35-43.

130.De Kimpe S. J., Kengatharan M., Thiemermann C. et all. The cell wall components peptidoglycan and lipoteichoic acid from Staphylococcus aureus act in synergy to cause shock and multiple organ failure // Proc. Natl. Acad. Sci. U. S.AVol.92, N22. - P..

131.Defraigne J. O., Canivet J. L. Vascular effects of NO.. Roles of NO. in septic shock and adult respiratory distress syndrome (ARDS) // Rev. Med. LiegeVol.50, N1. - P.26-34.

132.Denlinger L. C., Proctor R. A. Paradoxical neutrophil activation and coagulopathy during the recovery phase after endotoxemia // J. Crit. Care Med. – 2002. – Vol.29, N2.- P.452-453.

133.Demiryurek A. T., Cakici I., Kanzik I. Peroxynitrite: a putative cytotoxin // Pharmacol. ToxicolVol.82, N3. - P.113-117.

134.Dhaunsi G. S., Singh I., Hanevold C. D. Peroxisomal participation in the cellular response to the oxidative stress of endotoxin // Mol. Cell. BiochemVol.126, N1. - P.25-35.

135.Edmunds L. N. Clocks, cell cycles, cancer, and aging. Role of the adenylate cyclase-cycl // Ann. N. Y. Acad. SciVol.719.- P.77-96.

136.Eling T. E., Ally A. Pulmonary biosynthesis and metabolism of prostaglandine and related substances // Bull. Europ. Physiopath. respVol. 17. - P.611-625.

137.Feingold K. R., Grunfeld C. Role of cytokines in inducing hyperlipidemia // DiabetisVol. 41, Supp. 1-2. - P. 97-101.

138.Galanos C., Freudenberg M. A. Mechnisms of endotoxin shock and endotoxin hypersensitivity // ImmunobiologyVol. 187. - P. 346-356.

139.Gerbino A. J., Altemeier W. A., Schimmel C., Glenny R. W. Endotoxemia increases relative perfusion to dorsal-caudal lung regions // J. Appl. Physiol. – 2001.-Vol.90, N4. – P..

140.Giralt M., Gasull T., Blanquez A., et al. Effect of endotoxin on rat serum, lung and liver lipid peroxidation and on tissue metallothionein levels // Rev. Esp. FisiolVol.49, N2. - P.73-78.

141.Girotti A. W. Lipid hydroperoxide generation, turnover, and effector action in biological systems // J. Lipid. ResVol.39, N8. - P..

142.Gomez-Jimenez J., Martin M. C., Sauri R. et al. Interleukin-10 and the monocyte/macrophage-induced inflammatory pesponse in septic shock / // J. Infect. DisVol.171, N2. - P.472-475.

143.Goode H. F., Cowley H. C., Walker B. E. et al. Decreased antioxidant status and increased lipid peroxidation in patients with septic shock and secondary organ disfunction // Crit. Care. MedVol.23, N4. - P.646-651.

144.Gordon V. M., Leppla S. H. Proteolytic activation of bacterial toxins: role of bacterial and host cell proteases // Infect. ImmunVol.62, N2. - P.333-340.

145.Gutteridge J. M.C. Biological origin of free radicals, and mechanisms of antioxidant protection // Chem. Biol. InteractVol.91, N2-3. - P.133-140.

146.Hack C. E,. Aarden L. A., Thijs L. G. Role of cytokines in sepsis //Adv. ImmunolVol.66, - P.101-195.

147.Halliwell B., Chirico S. Lipid peroxidation: its mechanism, measurement, and significance // Amer. J. Clin. NutrVol.57, N5. - P.715-725.

148.Hanasawa K., Kodama M. Sepsis and organ failure--its pathogenesis and treatment // Nippon. Geka. Gakkai. ZasshiVol.99, N8. - P.523-527.

149.Herszenyi L., Plebani M., Carraro P. et al. Role and behavior of cathepsin B and cathepsin L in gastric cancer // Orv. HetilVol.136, N25. - P..

150.Horstmann R. D., Leippe M., Tannich E. Host tissue destruction by Entamoeba histolytica: molecules mediating adhesion, cytolysis, and proteolysis // Mem. Inst. Oswaldo. CruzVol.87, N5. - P.57-60.

151.Hoyal C. R., Giron-Calle J., Forman H. J. The alveolar macrophage as a model of calcium signaling in oxidative stress // J. Toxicol. Environ. Health. B. Crit. RevVol.1, N2. - P.117-134.

152.Hurley J. C. Antibiotic-induced release of endotoxin. A therapeutic paradox // Drug. SafVol.12, N3. - P.183-195.

153.Iguchi H., Kojo S., Ikeda M. Lipid peroxidation and disintegration of the cell membrane structure in cultures of rat lung fibroblasts treated with asbestos // J. Appl. ToxicolVol.13, N4. - P.269-275.

154.Jochum M., Machleidt W., Fritz H. Proteolysis-induced pathomechanisms in acute inflammation and related therapeutic approaches //Agents. Actions. SupplVol.42. - P.51-69.

155.Kelly K. A., Havrilla C. M., Brady T. C. Oxidative stress in toxicology: established mammalian and emerging piscine model systems //Environ. Health. PerspectVol.106, N7. - P.375-384.

156.Kennedy A. R. The Bowman-Birk inhibitor from soybeans as an anticarcinogenic agent // Am J. Clin. NutrVol.68. - Suppl. 6. - P.1406S-1412S.

157.Ketterer B. Glutathione S-transferases and prevention of cellular free radical damage // Free Radic. ResVol.28, N6. - P.647-658.

158.Kirikae T., Schade F. U., Zahringer U. et al The significance of the hydrophilic backbone and the hydrophobic fatty acid regions of lipid A for macrophage binding and cytokine induction. // FEMS Immunol. Med. MicrobiolVol.8, N1. - P.13-26.

159.Knight K. R., Burdon J. G., Cook L. et al. The proteinase-antiproteinase theory of emphysema: a speculative analys is ofrecent advances into the pathogenesis of emphysema // RespirologyJun - Vol.2, N2. - P.91-95.

160.Knop M., Schiffer H. H., Rupp S. et al Vacuolar/lysosomal proteolysis: proteases, substrates, mechanisms. // Curr. Opin. Cell. BiolVol.5, N6. - P.990-996.

161.Koeppel M. C., Sayag J. Proteolytic enzymes and their inhibitors //Allerg. Immunol. ParisVol.25, N7. - P.286-288.

162.Kos J., Lah T. T. Cysteine proteinases and their endogenous inhibitors: target proteins for prognosis, diagnosis and therapy in cancer (review) // Oncol. RepVol.5, N6. - P.1349-61.

163.Kourie J. I. Interaction of reactive oxygen species with ion transport mechanisms // Am J. PhysiolVol.275, N1. - P.1-24.

164.Lah T. T., Kos J. Cysteine proteinases in cancer progression and their clinical relevance for prognosis // Biol. ChemVol.379, N2. - P.125-130.

165.Levenson R. Isoforms of the Na, K-ATPase: family members in search of function // Rev. Physiol. Biochem. PharmacolVol.123. - P.1-45.

166.Lingrel J. B. Van-Huysse J., O'Brien W. et al. Structure-function studies of the Na, K-ATPase // Kidney. Int. SupplVol.44. - P.32-39.

167.Lusuardi M., Capelli A., Cerutti C. G. et al. Airways inflammationin subjects with chronic bronchitis who hawe never smoked / // ThoraxVol.49, N12. - P..

168.Lynn W. A., Cohen J. Adjunctive therapy for septic shock: A review of experimental approaches // Clinical Infectious DiseasesVol. 20. - P. 143-158.

169.Malchesky P. S., Zborowski M., Hou K. C. Extracorporeal techniquest of endotoxin removal: a review of the art and science // Adv. Ren. Replace. TherVol.2, N1. - P.60-69.

170.Manthous C. A., Hall J. B., Samsel R. W. Endotoxin in human disease. Part 1: Biochemistry, assay, and possible role in diverse disease states // ChestVol.104, N5. - P..

171.Martin M. C., Gomez-Jimenez J., Esteban F. et al. Cytokines and nitric oxide in streptococcal shock syndrome / // Med. Clin. BarcVol.104, N12. - P.458-460.

172.Matsumoto T., Yokoi K., Mukaida N. et al. Pivotal role of interleukin-8 in the acute respiratory distress syndrome and cerebral reperfusion injury / // J. Leukoc. BiolVol.62, N5. - P.581-587.

173.Matsuura M. The role of citokines in endotoxin activities // Nippon. Saikingaku. ZasshiVol.50, N2. - P.435-449.

174.Mayeux P. R. Pathobiology of lipopolysaccharide // J. Toxicol. Environ. HealthVol.51, N5. - P.415-435.

175.Mejbaum-Katzenellenbogen W. Turbidymetryczna mikrometoda oznaczania bialek tanina // Acta Biochim. PolN2. - P.279-296.

176.Messina M. Modern applications for an ancient bean: soybeans and the prevention and treatment of chronic disease // J-NutrVol.125, N3. - P.567S-569S.

177.Minamiyama Y., Takemura S., Imaoka S. et al. Inhibition of cytochrome P450 by nitric oxide / // Nippon. Yakurigaku. ZasshiVol.112, N1. - P.33-41.

178.Moller P., Wallin H. Adduct formation, mutagenesis and nucleotide excision repair of DNA damage produced by reactive oxygen species and lipid peroxidation product // Mutat. ResVol.410, N3. - P.271-290.

179.Morrison D. C. Antibiotic-mediated release of endotoxin and the pathogenesis of gram-negative sepsis // Prog. Clin. Biol. ResVol.397. - P.199-207.

180.Nadziejko C., Finkelstein I., Balmes J. R. Constribution of secretory leukocyte proteinase inhibitor to the antiprotease defense system of the peripheral lung: effect of ozone-induced acute inflammation // Amer. J. Respir. Crit. Care. MedVol.152, N5. - P..

181.Norrby-Teglund A., Pauksens K., Norgren M. et al. Correlation between serum TNF alpha and IL6 levels and severity of group A streptococcal infections // Scand. J. Infect. DisVol.27, N2. - P.125-130.

182.Nowak D., PietrasT., Antczak A., et al. Effect of bacterial lipopolysaccharide on the content of lipid peroxidation products in lungs and other organs of mice // Antonie Van Leeuwenhoek - 1993. - Vol.63, N1. - P.77-83.

183.Ogawa T. Immunobiological properties of chemically defined lipid A from lipopolysaccharide of Porphyromonas (Bacteroides) gingivalis // Eur. J. BiochemVol.219, N3. - P.737-742.

184.Okajima K. Antithrombin prevents endotoxin-induced pulmonary vascular injury by inhibiting leukocyte activation // Blood Coagul. FibrinolysisVol.9. - Suppl. 2. - P. S25-37.

185.Okamoto A, Hanagata H., Kawamura Y. et al. Anti-hypertensive substances in fermented soybean, natto / // Plant. Foods. Hum. Nutr.- 1995. - Vol.47, N1. - P.39-47.

186.Opal S. M., Yu R. L.Jr. Antiendotoxin strategies for the prevention and treatment of septic shock. New approaches and future directions // DrugsVol.55, N4. - P.497-508.

187.Parratt J. R. Nitric oxide. A key mediator in sepsis and endotoxaemia? // J. Physiol. PharmacolVol.48, N4. - P.493-506.

188.Parratt J. R. Nitric oxide in sepsis and endotoxaemia //J. Antimicrob. ChemotherVol.41, Suppl. A. - P.31-39.

189.Perichon R., Bourre J. M., Kelly J. F., Roth G. S. The role of peroxisomes in aging // Cell. Mol. Life. SciVol.54, N7. - P.641-652.

190.Pina J. S., Horan M. P. Alpha 1-antitrypsin deficiency and asthma. The continuing search for the relationship // Postgrad. MedVol.101, N4. - P.153-156, 159-162, 167-168.

191.Potter S. M. Overview of proposed mechanisms for the hypocholesterolemic effect of soy. // J. Nutr.- 1995.- Vol.125, N3 (Suppl).- P.606S-611S.

192.Pruitt J. H., Copeland E. M., Moldawer L. L. Interleukin-1 and interleukin-1 antagonism in sepsis, systemic inflammatory response syndrome, and septic shock // ShockVol.3, N4. - P.235-251.

193.Rietschel E. T., Kirikae T., Schade F. U. et al Bacterial endotoxin: molecular relationships of structure to activity and function. // FASEB JVol.8, N2. - P.217-225.

194.Robinson B. H. The role of manganese superoxide dismutase in health and disease // J. Inherit. Metab. DisVol.21, N5. - P.598-603.

195.Romero C., Bosch M. A. Effect of dimethylthiourea in phosphatidylcholine biosynthesis by rat lung during reversible endotoxic shock // Mol. Cell. BiochemVol.118, N1. - P.1-7.

196.Sartin J. L., Elsasser T. H., Gunter D. R., McMahon C. D. Endocrine modulation of physiological responses to catabolic disease // Domest. Anim. EndocrinolVol.15, N5. - P.423-429.

197.Schwartz M. K. Tissue cathepsins as tumor markers // Clin. Chim. ActaVol.237, NN1-2. - P.67-78.

198.Sepper R., Konttinen Y. T., Ingman. T. et al. Presence, activities, and molecular forms of cathepsin G, elastase, alpha 1-antitrypsin, and alpha 1-antichymotrypsin in bronchiectasis // J. Clin. ImmunolVol.15, N1. - P.27-34.

199.Shah N. S., Billiar T. R. Role of Nitric Oxide in Inflammation and Tissue Injury during Endotoxemia and Hemorrhagic Shock // Environ. Health. PerspectVol.106, Suppl. 5. - P..

200.Singer S. J., Nicholson G. L. The fluid mosaic model of cell membranes // ScienceVol.175. - P.720-731.

201.Skulachev V. P. The laws of cell energetics // Eur. J. BiochemVol.208, N2. - P.203-209.

202.Smith, J. B., Nguyen T. T., Hughes, H. J. et al. Glucocorticoid-attenuated response genes induced in the lung during endotoxemia // Am. J. Physiol. Lung Cell. Mol. Physiol - 2002. - Vol.283, N3, - P. L.

203.Spolarics Z. Endotoxemia, pentose cycle, and the oxidant/antioxidant balance in the hepatic sinusoid // J. Leukoc. BiolVol.63, N5. - P.534-541.

204.Sriskandan S., Cohen J. The pathogenesis of septic shock // J. InfectVol.30, N3. - P.201-206.

205.Supinski G. Free radical induced respiratory muscle dysfunction //Mol. Cell. BiochemVol.179, NN1-2. - P.99-110.

206.Taylor R., Agius L. The biochemistry of diabetes // Biochem JVol.250. - P.625-640.

207.Ulevitch R. J., Tobias P. S. Receptor-dependet mechanisms of cell stimulation by bacterial endotoxin // Annu. Rev. ImmunolN13. - P.437-457.

208.Vane J. R. The release and fate of vasoactive hormones in circulation // Brit. J. pharmacolVol. 35. - P.209-242.

209.Van Steenbergen W. Alpha 1-antitrypsin deficiency: an overview //Acta. Clin. BelgVol.48, N3. - P.171-189.

210.Watson R. W., Redmond H. P., Bouchier-Hayes D. Role of endotoxin in mononuclear phagocyte-mediated inflammatory responses // J. Leukoc. BiolVol.56, N1. - P.95-103.

211.Watterberg K. L., Carmichael D. F., Gerdes J. S. et al. Secretory leukocyte protease inhibitor and lung inflammation in developing bronchopulmonary dysplasia / // J. PediatrVol.125, N2. - P.264-269.

212.West J. B. Physiological basis of medical practice. Twelfth Edition. - Baltimore: Wi Williams & Wilkins, 19P.

213.Wolfe T. A., Dasta J/F. Use of nitric oxide synthase inhibitors as a novel treatment for septic shock // Ann. PharmacotherVol.29, N1. - P.36-46.

214.Wright S. D., Kolesnick R. N. Does endotoxin stimulate cells by mimicking ceramide? // Immunol. TodayVol.16, N6. - P.297-302.

215.Youn Y. K., Knox J., Lalonde C. et al. Pentoxifylline does not prevent endotoxin induced lung and liver lipid peroxidation in the adult sheep / //Circ. ShockVol.39, N1. - P.39-43.

216.Zivot J. B., Hoffman W. D. Pathogenic effects of endotoxin // New. HorizVol.3, N2. - P.267-275.

217..Zidek Z., Masek K. Erratic behavior of nitric oxide within the immune system: illustrative review of conflicting data and their immunopharmacological aspects // Int. J. ImmunopharmacolVol.20, N7. - P.319-343.